Isolation of human eosinophils: microbead method has no impact on IL-5 sustained viability

Exp Dermatol. 2010 May;19(5):467-9. doi: 10.1111/j.1600-0625.2009.00974.x. Epub 2009 Sep 15.

Abstract

Background/purpose: In a recent issue of Experimental Dermatology (18, 2009, 654), Schefzyk et al. concluded that multi-antibody eosinophil isolation (Miltenyi) should be abandoned, as differential purity was minimal, and eosinophils underwent accelerated apoptosis when compared with those isolated with traditional anti-CD16 microbeads. Our intent was to investigate the universality of these findings.

Methods: We isolated eosinophils from normal donor granulocyte packs using two methods, and evaluated purity, viability and annexin-V/propidium-iodide staining.

Results: Purity was substantially greater when multi-antibody isolation was used for eosinophil isolation from granulocyte packs (98% vs 69%). No differential survival was detected when eosinophils were maintained in culture with or without interleukin-5.

Conclusions: Multi-antibody eosinophil isolation represents a substantial advantage over anti-CD-16 microbeads when isolating large numbers of eosinophils from concentrated leucocyte preparations. No differential survival was observed. While appropriate consideration of methods is always crucial, multi-antibody eosinophil isolation should not be abandoned completely.

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antibodies / chemistry
  • Antibodies / immunology
  • Antigens, CD / immunology
  • Apoptosis / drug effects
  • Biotinylation
  • Cell Count
  • Cell Separation / methods
  • Cell Survival / drug effects
  • Eosinophils / cytology*
  • Eosinophils / drug effects
  • Humans
  • Interleukin-5 / pharmacology*
  • Microspheres*
  • Monocytes / cytology
  • Neutrophils / cytology

Substances

  • Antibodies
  • Antigens, CD
  • IL5 protein, human
  • Interleukin-5